Document rB5gza7XaOOEewMZebmK30pX0

--B MPhmfbhhe , AMA rmmm Rr mm IM Sp.ecialy Materials eceonnessen 1? PEN f] December 20,2001 FYr-0102. || Document Processing Center (7407) SIM 40OUf1sficMeEoSntfvrPieorelotlmueStnWitoanlPrPreovteencttiioonn aAngdeTroexyics Washington, D.C. 20460 ARR26_ 1046 01378 EEECEEIVEED ABIRTOT dmaingo _ MRE 76 CoE Attention: For Your Information Docket -- Docket No. AR-226 Re: Information on Perfluorooctane Sulfonates and Related Compounds = DearSir or Madam: s= g3m: This continues M's voluntary submissionsofdata on perfluorooctane sulfonates and 301 related compounds, as partof ourongoingdialogue with EPA regarding fluorochemicald; 375 { We are enclosing two studies as more fully described below. Enclosed you will find the following: &a = ~ | 1. Final Report. A Cross-sectional Analysisof Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Clinical Chemistry, `Thyroid Hormone, Hematology and Urinalysis Results from Male and Female Employee Participantsof the 2000 Antwerp and Decatur Fluorochemical Medical Surveillance Program, October 11, 2001 2. aFinndalPeRrefplourotr,ooActLaonnogaitteud(iPnFaOlAA)naLleyvseilsos finSReerlautmioPnertfolLuiopriodocatnadneHseuplaftoincatCeli(nPiFcaOlS) Chemistry Test Results from Male Employee Participants of the 1994/95, 1997 and 2000 Fluorochemical Medical Surveillance Program, October 11, 2001. We will cont look forward inue to to our provide continui in ng formation dialogue on a with regular basi the agency. s as it beco Please feel mes available. free to contact We me with any questions. " tui Af oemis sec Michael A. Santoro >. Director of Environmental, Health Safety and Regulatory Affairs Specialty Materials Markets 3M SBtuilPdailn.g M23N6-15B5-11404 FYI-00-001378 5 IN AL 0R 000000/ contain NO CRI | 850620000008